Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-008258
Filing Date
2024-11-19
Accepted
2024-11-19 16:00:18
Documents
55
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR SEPT 2024 mosaic_i10q-093024.htm   iXBRL 10-Q 758827
2 CERTIFICATION mosaic_ex3101.htm EX-31.1 8027
3 CERTIFICATION mosaic_ex3102.htm EX-31.2 8035
4 CERTIFICATION mosaic_ex3201.htm EX-32.1 4508
5 CERTIFICATION mosaic_ex3202.htm EX-32.2 4661
  Complete submission text file 0001683168-24-008258.txt   3310606

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cpmv-20240930.xsd EX-101.SCH 29593
7 XBRL CALCULATION FILE cpmv-20240930_cal.xml EX-101.CAL 36696
8 XBRL DEFINITION FILE cpmv-20240930_def.xml EX-101.DEF 118370
9 XBRL LABEL FILE cpmv-20240930_lab.xml EX-101.LAB 237086
10 XBRL PRESENTATION FILE cpmv-20240930_pre.xml EX-101.PRE 207381
57 EXTRACTED XBRL INSTANCE DOCUMENT mosaic_i10q-093024_htm.xml XML 302981
Mailing Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646
Business Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646 657-208-0890
Mosaic ImmunoEngineering Inc. (Filer) CIK: 0000836564 (see all company filings)

EIN.: 841070278 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22182 | Film No.: 241475883
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)